- Pregnancy rapid test kits
- Fertility rapid test
Pregnancy Testing Market size was valued at USD 1260 million in 2022 and is poised to grow at a CAGR of 5.14% from 2023-29. Pregnancy testing kits are used for early detection of pregnancy. Home pregnancy tests are simple and easy to use, inexpensive and provide accurate results within minutes. Most of the pregnancy tests are being taken in the home provides. The resulting accuracy is up to 97% to 99% when they are used as per the instructions. Urine pregnancy kit will be used for the detection of HCG hormone, a hormone which is only produced in the body of the pregnant woman. HCG production will be increased in initial days of the pregnancy which will be getting doubled for every 2-3 days in blood. Presence of HCG above a specific range will confirm pregnancy. There are several prominent factors that increase the demand for pregnancy test kits such as increasing disposable income, adoption of technological development for detecting pregnancy and growing healthcare expenditure.
However, lack of technical proficiency in a woman is a major restraining factor. Increasing demand for easy way to obtain faster results and easily attainable pregnancy kits in online stores and pharmacy stores lead towards the increase in demand for pregnancy test kits. Pregnancy Testing Market not always readily available to such ladies. Dip-strip tests that are simple to use and highly accurate can be acquired for less than ten cents from manufacturers. Furthermore, Pregnancy Testing Market are not widely available in low-income nations, and a lack of awareness, combined with a low literacy rate among women, further inhibits the sale of pregnancy test kits in these countries. As a result, problems such as a lack of awareness and the lack of availability of pregnancy test kits are anticipated to stymie the market's expansion.
Global Pregnancy Testing Market Summary
Study Period
2023-29
Base Year
2022
CAGR
5.14%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Pregnancy Testing Market Dynamics
A surge in the number of unintended pregnancies increased awareness among women is expected to offer enormous growth opportunities for the market players. According to World Health Organization statistics, in 2015 over 40% of the pregnancy cases which are reporting every year are unintended & about 10% of the pregnancy cases were of teenage. A rise in the number of unintended pregnancies is expected to create demand for pregnancy test kits. Moreover, increasing promotional campaigns undertaken by the manufacturers like celebrity endorsing in order to influence the rural people about utilization of the pregnancy detection devices is expected to bolster pregnancy testing market growth. The market is growing due to reasons like 99% accuracy rate in identifying HCG levels from the day of an expected period of the women. Manufacturers are focussing on the new product launches, market expansions, mergers, acquisitions and collaborations which are also showing positive influence on the growth of the market.
North America Got Significant Share Of
Pregnancy Testing Market Regional Analysis
North America is expected to dominate the pregnancy testing market owing to high healthcare expenditure and awareness programmes by companies for effective usage of pregnancy test kits. Europe is expected to expand at robust growth rate owing to the high adaptation of the digital pregnancy detecting kits along with the increasing disposable incomes. Asia Pacific is anticipated to show a significant growth owing to the increasing adaptation of pregnancy testing kits in the rural areas. Latin America is also emerging as a significant market owing to the growing awareness regarding the benefits of the early pregnancy detection and affordability of pregnancy detection kits.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Pregnancy Testing Market Segmentation
By Product
By Test Type
- Follicle stimulating hormone (FSH) test
- Human chorionic gonadotropin hormone blood test
- Urine test
- Luteinizing hormone (LH) test
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Gynaecology clinics
- Hypermarkets or supermarkets
Frequently Asked Questions
The pregnancy testing market size was valued at USD 1260 million in 2022
The pregnancy testing market key players are Procter & Gamble Co (U.S.) Alere Inc. (U.S.) Church & Dwight (U.S.) Germaine Laboratories (U.S.) SPD Swiss Precision Diagnostics (Switzerland) Â Piramal Enterprises (India), Abbott Laboratories (U.S.) DCC plc (Ireland) Cardinal Health (U.S.) Prestige Brands Holdings (U.S.)
The pregnancy testing market drivers are increase in unplanned pregnancies
| 1. Executive Summary |
| 2. Global Pregnancy Testing Market Introduction |
| 2.1.Global Pregnancy Testing Market - Taxonomy |
| 2.2.Global Pregnancy Testing Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Test Type |
| 2.2.3. Distribution Channel |
| 2.2.4.Region |
| 3.Global Pregnancy Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Pregnancy Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Pregnancy Testing Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Pregnancy rapid test kits |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Fertility rapid test |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Pregnancy Testing Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Follicle stimulating hormone (FSH) test |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Human chorionic gonadotropin hormone blood test |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Urine test |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Luteinizing hormone (LH) test |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Pregnancy Testing Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospital Pharmacies |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Retail Pharmacies |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Online Pharmacies |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Gynaecology clinics |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Hypermarkets or supermarkets |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Pregnancy Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Pregnancy Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Pregnancy rapid test kits |
| 9.1.2.Fertility rapid test |
| 9.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Follicle stimulating hormone (FSH) test |
| 9.2.2.Human chorionic gonadotropin hormone blood test |
| 9.2.3.Urine test |
| 9.2.4.Luteinizing hormone (LH) test |
| 9.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital Pharmacies |
| 9.3.2.Retail Pharmacies |
| 9.3.3.Online Pharmacies |
| 9.3.4.Gynaecology clinics |
| 9.3.5.Hypermarkets or supermarkets |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Pregnancy Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Pregnancy rapid test kits |
| 10.1.2.Fertility rapid test |
| 10.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Follicle stimulating hormone (FSH) test |
| 10.2.2.Human chorionic gonadotropin hormone blood test |
| 10.2.3.Urine test |
| 10.2.4.Luteinizing hormone (LH) test |
| 10.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital Pharmacies |
| 10.3.2.Retail Pharmacies |
| 10.3.3.Online Pharmacies |
| 10.3.4.Gynaecology clinics |
| 10.3.5.Hypermarkets or supermarkets |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Pregnancy Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Pregnancy rapid test kits |
| 11.1.2.Fertility rapid test |
| 11.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Follicle stimulating hormone (FSH) test |
| 11.2.2.Human chorionic gonadotropin hormone blood test |
| 11.2.3.Urine test |
| 11.2.4.Luteinizing hormone (LH) test |
| 11.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital Pharmacies |
| 11.3.2.Retail Pharmacies |
| 11.3.3.Online Pharmacies |
| 11.3.4.Gynaecology clinics |
| 11.3.5.Hypermarkets or supermarkets |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Pregnancy Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Pregnancy rapid test kits |
| 12.1.2.Fertility rapid test |
| 12.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Follicle stimulating hormone (FSH) test |
| 12.2.2.Human chorionic gonadotropin hormone blood test |
| 12.2.3.Urine test |
| 12.2.4.Luteinizing hormone (LH) test |
| 12.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital Pharmacies |
| 12.3.2.Retail Pharmacies |
| 12.3.3.Online Pharmacies |
| 12.3.4.Gynaecology clinics |
| 12.3.5.Hypermarkets or supermarkets |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Pregnancy Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Pregnancy rapid test kits |
| 13.1.2.Fertility rapid test |
| 13.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Follicle stimulating hormone (FSH) test |
| 13.2.2.Human chorionic gonadotropin hormone blood test |
| 13.2.3.Urine test |
| 13.2.4.Luteinizing hormone (LH) test |
| 13.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital Pharmacies |
| 13.3.2.Retail Pharmacies |
| 13.3.3.Online Pharmacies |
| 13.3.4.Gynaecology clinics |
| 13.3.5.Hypermarkets or supermarkets |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Procter & Gamble Co (U.S.) |
| 14.2.2.Alere Inc. (U.S.) |
| 14.2.3.Church & Dwight (U.S.) |
| 14.2.4.Germaine Laboratories (U.S.) |
| 14.2.5.SPD Swiss Precision Diagnostics (Switzerland) |
| 14.2.6.Piramal Enterprises (India), |
| 14.2.7.Abbott Laboratories (U.S.) |
| 14.2.8.DCC plc (Ireland) |
| 14.2.9.Cardinal Health (U.S.) |
| 14.2.10.Prestige Brands Holdings (U.S.) |
| 14.2.11.Kent Pharmaceuticals (UK) |
| 14.2.12.Quidel Corporation (U.S.). |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Procter & Gamble Co (U.S.)
- Alere Inc. (U.S.)
- Church & Dwight (U.S.)
- Germaine Laboratories (U.S.)
- SPD Swiss Precision Diagnostics (Switzerland)
- Piramal Enterprises (India),
- Abbott Laboratories (U.S.)
- DCC plc (Ireland)
- Cardinal Health (U.S.)
- Prestige Brands Holdings (U.S.)
- Kent Pharmaceuticals (UK)
- Quidel Corporation (U.S.).